Study of a new drug for HER2-positive advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug for people with advanced or metastatic HER2-positive solid tumors. The drug is designed to target cancer cells with HER2 and may slow tumor growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic cancer that cannot be surgically removed
- Your tumor is HER2-positive (a protein that may help cancer grow)
- You have at least one measurable tumor (can be seen on scans)
- You are expected to live at least 12 weeks or more
- You are generally active (able to do light work) and weigh at least 35 kg
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HMPL-A580 in people with advanced or metastatic solid tumors that cannot be removed by surgery. The goal is to see if it is safe and effective.
This Phase 1 trial tests HF158K1 in people with advanced solid tumors that have HER2 protein. It aims to see if the drug can be given safely and learn how it works in people whose cancer shows HER2 on tumor testing.
This study tests a new drug for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, helps shrink tumors, and improves quality of life.
This study tests a new drug called KM257 for people with advanced solid tumors that have a high level of a protein called HER2. The drug is given as an infusion and is designed to target cancer cells with this protein, potentially slowing or stopping tumor growth.
This study tests an investigational drug (KM501) for advanced solid tumors that have HER2 changes. It aims to see if the drug can shrink tumors or slow their growth, and whether it is safe for patients who have run out of standard options.
This trial tests an investigational drug (SHR-4602) alone or with other treatments for advanced solid tumors that have HER2. The goal is to see if it can shrink or control the cancer.
Hear when a new Solid Tumors, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.